Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

R Gniadecki, Knud Kragballe, Hans Thorhauge Dam, L Skov

    202 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab